217 related articles for article (PubMed ID: 8709686)
1. Delta: a randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals. Delta Coordinating Committee.
Lancet; 1996 Aug; 348(9023):283-91. PubMed ID: 8709686
[TBL] [Abstract][Full Text] [Related]
2. A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team.
Hammer SM; Katzenstein DA; Hughes MD; Gundacker H; Schooley RT; Haubrich RH; Henry WK; Lederman MM; Phair JP; Niu M; Hirsch MS; Merigan TC
N Engl J Med; 1996 Oct; 335(15):1081-90. PubMed ID: 8813038
[TBL] [Abstract][Full Text] [Related]
3. Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults.
Darbyshire J; Foulkes M; Peto R; Duncan W; Babiker A; Collins R; Hughes M; Peto T; Walker A
Cochrane Database Syst Rev; 2000; (3):CD002038. PubMed ID: 10908523
[TBL] [Abstract][Full Text] [Related]
4. Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults.
Darbyshire J; Foulkes M; Peto R; Duncan W; Babiker A; Collins R; Hughes M; Peto T; Walker A
Cochrane Database Syst Rev; 2000; 2000(2):CD002038. PubMed ID: 10796851
[TBL] [Abstract][Full Text] [Related]
5. CPCRA 007: preliminary results of combination antiretroviral study.
Randall P
NIAID AIDS Agenda; 1996 Mar; ():2. PubMed ID: 11363796
[TBL] [Abstract][Full Text] [Related]
6. Zidovudine, didanosine, and zalcitabine in the treatment of HIV infection: meta-analyses of the randomised evidence. HIV Trialists' Collaborative Group.
Lancet; 1999 Jun; 353(9169):2014-25. PubMed ID: 10376616
[TBL] [Abstract][Full Text] [Related]
7. An evaluation of HIV RNA and CD4 cell count as surrogates for clinical outcome. Delta Coordinating Committee and Virology Group.
AIDS; 1999 Apr; 13(5):565-73. PubMed ID: 10203381
[TBL] [Abstract][Full Text] [Related]
8. Studies of zidovudine in combination with didanosine and zalcitabine.
Jablonowski H
J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S52-6. PubMed ID: 8595509
[TBL] [Abstract][Full Text] [Related]
9. AZT delta study: major European/Australian study finds combinations better than AZT alone.
King E
AIDS Treat News; 1995 Oct; (no 232):3-4. PubMed ID: 11362876
[TBL] [Abstract][Full Text] [Related]
10. Zidovudine alone or in combination with didanosine or zalcitabine in HIV-infected patients with the acquired immunodeficiency syndrome or fewer than 200 CD4 cells per cubic millimeter. Investigators for the Terry Beirn Community Programs for Clinical Research on AIDS.
Saravolatz LD; Winslow DL; Collins G; Hodges JS; Pettinelli C; Stein DS; Markowitz N; Reves R; Loveless MO; Crane L; Thompson M; Abrams D
N Engl J Med; 1996 Oct; 335(15):1099-106. PubMed ID: 8813040
[TBL] [Abstract][Full Text] [Related]
11. Data and safety monitoring in the Delta trial.
Armitage P
Control Clin Trials; 1999 Jun; 20(3):229-41. PubMed ID: 10357496
[TBL] [Abstract][Full Text] [Related]
12. Survival in HIV-infected patients who have received zidovudine: comparison of combination therapy with sequential monotherapy and continued zidovudine monotherapy. Multicenter AIDS Cohort Study Group.
Graham NM; Hoover DR; Park LP; Stein DS; Phair JP; Mellors JW; Detels R; Saah AJ
Ann Intern Med; 1996 Jun; 124(12):1031-8. PubMed ID: 8633816
[TBL] [Abstract][Full Text] [Related]
13. Benefits of combination therapy confirmed.
Cheng B
PI Perspect; 1995 Dec; (no 17):3-4. PubMed ID: 11363111
[TBL] [Abstract][Full Text] [Related]
14. Combination therapy with ZDV + DDI versus ZDV + DDC in patients with progression of HIV-infection under treatment with ZDV.
Mauss S; Adams O; Willers R; Jablonowski H
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Apr; 11(5):469-77. PubMed ID: 8605592
[TBL] [Abstract][Full Text] [Related]
15. The impact of ethanol and Marinol/marijuana usage on HIV+/AIDS patients undergoing azidothymidine, azidothymidine/dideoxycytidine, or dideoxyinosine therapy.
Whitfield RM; Bechtel LM; Starich GH
Alcohol Clin Exp Res; 1997 Feb; 21(1):122-7. PubMed ID: 9046384
[TBL] [Abstract][Full Text] [Related]
16. Studies confirm value of early and combination treatments.
Vazquez E
Posit Aware; 1995; VI(6):8. PubMed ID: 11363148
[TBL] [Abstract][Full Text] [Related]
17. Antiretroviral combination treatment prolongs life in people with HIV/AIDS.
Cooper EC
AMFAR Rep; 1996 Jan; ():1-5. PubMed ID: 11363617
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind trial of half versus standard dose of zidovudine plus zalcitabine in Thai HIV-1-infected patients (study HIV-NAT 001). HIV Netherlands Australia Thailand Research Collaboration.
Kroon ED; Ungsedhapand C; Ruxrungtham K; Chuenyam M; Ubolyam S; Newell ME; van Leeuwen R; Kunanusont C; Buranapraditkul S; Sirivichayakul S; Lange JM; Cooper DA; Phanuphak P
AIDS; 2000 Jul; 14(10):1349-56. PubMed ID: 10930149
[TBL] [Abstract][Full Text] [Related]
19. Major study shows AZT monotherapy inferior.
James JS
AIDS Treat News; 1995 Sep; (no 231):3-4. PubMed ID: 11362867
[TBL] [Abstract][Full Text] [Related]
20. ACTG 175 and Delta.
Torres G
GMHC Treat Issues; 1995 Oct; 9(10):2-3. PubMed ID: 11362915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
